US Stock MarketDetailed Quotes
ERNA Eterna Therapeutics
- 1.070
- +0.030+2.88%
Close Nov 4 16:00 ET
- 1.120
- +0.050+4.66%
Post 20:01 ET
5.79MMarket Cap-241P/E (TTM)
1.120High1.035Low10.27KVolume1.070Open1.040Pre Close11.20KTurnover0.31%Turnover RatioLossP/E (Static)5.41MShares2.62552wk High-0.68P/B3.51MFloat Cap0.83552wk Low--Dividend TTM3.28MShs Float1613.400Historical High--Div YieldTTM8.17%Amplitude0.835Historical Low1.089Avg Price1Lot Size
Eterna Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 47K | 47K | 68K | 17K | 51K | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --47K | --47K | --68K | --17K | --51K | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 95K | 22.00%61K | 236K | 66K | 120K | 0 | 50K | 0 | 0 | 0 |
| Gross profit | -48K | 72.00%-14K | -168K | -49K | -69K | 0 | -50K | 0 | 0 | 0 |
| Operating expense | 19.42%4.88M | 9.63%5.77M | -23.90%20.51M | 0.99%5.72M | -34.54%5.44M | -42.55%4.09M | -16.36%5.27M | -1.76%26.95M | -33.68%5.66M | 45.05%8.3M |
| Selling and administrative expenses | 50.42%3.9M | 20.13%4.32M | -11.89%14.59M | 21.85%4.51M | 19.10%3.98M | -52.33%2.59M | -20.43%3.59M | 12.44%16.56M | -13.72%3.7M | -21.09%3.34M |
| -General and administrative expense | 50.42%3.9M | 20.13%4.32M | -11.89%14.59M | 21.85%4.51M | 19.10%3.98M | -52.33%2.59M | -20.43%3.59M | 12.44%16.56M | -13.72%3.7M | -21.09%3.34M |
| Research and development costs | -34.16%987K | -12.90%1.46M | -43.03%5.92M | -38.33%1.21M | -70.64%1.46M | -11.04%1.5M | -6.06%1.67M | -18.21%10.39M | -53.82%1.96M | 232.86%4.96M |
| Operating profit | -20.59%-4.93M | -8.86%-5.79M | 23.28%-20.67M | -1.86%-5.77M | 33.71%-5.51M | 42.55%-4.09M | 15.57%-5.32M | 1.76%-26.95M | 33.68%-5.66M | -45.05%-8.3M |
| Net non-operating interest income expense | -3,420.83%-797K | -78,700.00%-786K | -1,486.67%-476K | -6,366.67%-388K | -1,040.00%-114K | 284.62%24K | 200.00%1K | 59.46%-30K | 66.67%-6K | 50.00%-10K |
| Non-operating interest income | ---- | ---- | --138K | ---- | ---- | --24K | --1K | --0 | ---- | ---- |
| Non-operating interest expense | --797K | --786K | 1,946.67%614K | 8,666.67%526K | 1,040.00%114K | ---- | ---- | -59.46%30K | -66.67%6K | -50.00%10K |
| Other net income (expense) | 146.01%202K | 27.08%-70K | -121.33%-521K | -100.33%-4K | -98.01%20K | -111.76%-439K | 96.88%-96K | 102.57%2.44M | 83.01%1.22M | 101.25%1M |
| Gain on sale of security | -25.68%136K | -55.56%-70K | -98.42%156K | -83.28%49K | -98.01%20K | -98.26%183K | 97.68%-45K | --9.85M | --293K | --1M |
| Earnings from equity interest | ---- | --0 | ---- | ---- | ---- | ---- | ---51K | ---- | ---- | ---- |
| Special income (charges) | 119.30%66K | ---- | 94.53%-343K | --0 | --0 | 94.94%-342K | ---- | 93.40%-6.27M | 36.34%923K | --0 |
| -Less：Restructuring and merger&acquisition | 44.07%-66K | ---- | ---118K | --0 | --0 | ---118K | ---- | --0 | --0 | --0 |
| -Less:Other special charges | ---- | ---- | --460K | --0 | ---- | --460K | ---- | ---- | ---- | ---- |
| -Write off | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --5.99M | --0 | --0 |
| -Gain on sale of property,plant,equipment | ---- | ---- | 99.64%-1K | --0 | ---- | ---- | ---- | 97.10%-280K | 1,061.54%151K | ---- |
| Other non- operating income (expenses) | ---- | ---- | 70.73%-334K | -5,400.00%-53K | ---- | -27,900.00%-280K | ---- | -114,000.00%-1.14M | 108.33%1K | ---- |
| Income before tax | -22.69%-5.53M | -22.77%-6.64M | 11.67%-21.67M | -38.39%-6.16M | 23.42%-5.6M | -32.55%-4.5M | 42.28%-5.41M | 79.97%-24.53M | 43.60%-4.45M | 91.50%-7.31M |
| Income tax | -25.00%3K | -20.00%4K | -106.67%-3K | -110.00%-4K | -260.00%-8K | 4K | 5K | -29.69%45K | -37.50%40K | 5K |
| Net income | -22.65%-5.53M | -22.73%-6.65M | 11.84%-21.67M | -37.07%-6.15M | 23.58%-5.59M | -32.67%-4.51M | 42.23%-5.42M | 79.94%-24.58M | 43.55%-4.49M | 91.49%-7.32M |
| Net income continuous Operations | -22.65%-5.53M | -22.73%-6.65M | 11.84%-21.67M | -37.07%-6.15M | 23.58%-5.59M | -32.67%-4.51M | 42.23%-5.42M | 79.94%-24.58M | 43.55%-4.49M | 91.49%-7.32M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -22.65%-5.53M | -22.73%-6.65M | 11.84%-21.67M | -37.07%-6.15M | 23.58%-5.59M | -32.67%-4.51M | 42.23%-5.42M | 79.94%-24.58M | 43.55%-4.49M | 91.49%-7.32M |
| Preferred stock dividends | 0.00%8K | 0.00%16K | 0.00%8K | 0.00%8K | 0.00%16K | 0.00%8K | ||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -22.61%-5.54M | -22.73%-6.65M | 11.84%-21.68M | -37.00%-6.16M | 23.58%-5.59M | -32.59%-4.52M | 42.23%-5.42M | 79.93%-24.6M | 43.51%-4.5M | 91.49%-7.32M |
| Basic earnings per share | -20.00%-1.02 | -16.04%-1.23 | 49.38%-4.08 | 8.06%-1.14 | 58.63%-1.03 | 26.72%-0.85 | 69.71%-1.06 | 85.76%-8.06 | 61.25%-1.24 | 92.68%-2.49 |
| Diluted earnings per share | -20.00%-1.02 | -16.04%-1.23 | 49.38%-4.08 | 8.06%-1.14 | 58.63%-1.03 | 26.72%-0.85 | 69.71%-1.06 | 85.76%-8.06 | 61.25%-1.24 | 92.68%-2.49 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data